Association between glycemic control and albuminuria among Peruvian adults with diabetes mellitus 2
a cross-sectional analytical study
Palavras-chave:
Diabetes mellitus, Albuminuria, Glycated hemoglobin A, Diabetes complications, PeruResumo
BACKGROUND: Albuminuria is a risk factor for microvascular and macrovascular complications in the diabetic population. However, few studies have correlated poor glycemic control and albuminuria prevalence in Hispanic populations. OBJECTIVE: To evaluate the association between glycemic control and albuminuria among Peruvian adults with type 2 diabetes mellitus (T2DM). DESIGN AND SETTING: Cross-sectional analytical study among adults with T2DM in Lima, Peru. METHODS: We included adults over 18 years old who were in a clinical follow-up program at a private clinic in Lima in 2018. Poor glycemic control was defined as a serum value of glycosylated hemoglobin A1C (HbA1C) ≥ 7%. Albuminuria was defined as albumin values > 30 mg/dl in the first morning urine. We generated generalized linear regression models from the Poisson family with robust variance. We calculated the crude and adjusted prevalence ratios (PRs) with their 95% confidence interval (CI). RESULTS: We analyzed 907 participants of median age 58 years (interquartile range, IQR 49 to 66), and 62.8% were males. The prevalence of poor glycemic control was 39.8%, and the prevalence of albuminuria was 22.7%. The prevalences of albuminuria in groups with poor glycemic control and adequate glycemic control were 32.7% and 16.1%, respectively. In the adjusted regression analysis, we found a statistically significant association between poor glycemic control and albuminuria (annual percentage rate, aPR = 1.70; 95% CI: 1.28-2.27). CONCLUSIONS: The prevalence of poor glycemic control and albuminuria was high in our study population. Moreover, Peruvian T2DM adults with poor glycemic control were more likely to have albuminuria.
Downloads
Referências
International Diabetes Federation. IDF Diabetes Atlas. 7th edition. 2015. Available from: https://www.diabetesatlas.org/upload/resources/previous/files/7/IDF%20Diabetes%20Atlas%207th.pdf Accessed in 2021 (Dec 13).
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81. PMID: 29496507; https://doi.org/10.1016/j.diabres.2018.02.023.
Lerner A, Bernabe-Ortiz A, Gilman RH, Smeeth L, Miranda JJ. The “rule of halves” does not apply in Peru: awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants. Crit Pathw Cardiol. 2013;12(2):53-8. PMID: 23680809; https://doi.org/10.1097/HPC.0b013e318285ef60.
Huayanay-Espinoza IE, Guerra-Castañon F, Lazo-Porras M, et al. Metabolic control in patients with type 2 diabetes mellitus in a public hospital in Peru: A cross-sectional study in a low-middle income country. PeerJ. 2016;4:e2577. PMID: 27761351; https://doi.org/10.7717/peerj.2577.
Sánchez MA, Gonzales YM. Factores determinantes en las complicaciones de Diabetes Mellitus tipo 2 (DM 2) en adultos y adultos mayores atendidos en el Centro de Atención Primaria (CAP) III Es Salud–El Agustino, 2016. Rev Investig Apunt Cient Estud Nutr Humana. 2017;1(1). Available from: https://revistas.upeu.edu.pe/index.php/r_nutricion/article/view/943 Accessed in 2021 (Dec 13).
Villena JE. Epidemiología de la Diabetes mellitus en el Perú. Diagnóstico. 2018;55(4):173–82. Available from: http://142.44.242.51/index.php/diagnostico/article/view/21 Accessed in 2021 (Dec 13).
Taype-Rondan A, Lazo-Porras M, Moscoso-Porras M, Moreano-Sáenz M, Miranda JJ. Inadequate glycaemic control in LMIC: health system failures in Peru. Br J Gen Pract. 2016;66(645):197. PMID: 27033486; https://doi.org/10.3399/bjgp16X684541.
Cardenas MK, Morán D, Beran D, Miranda J. Identificando las barreras de acceso a la atención y tratamiento de la hipertensión y diabetes en Lima, Perú; 2014. Available from: https://www.cronicas-upch.pe/wp-content/uploads/2014/08/Alliance-Final-Research-Report-SPANISH-WEB.pdf Accessed in 2021 (Dec 13).
Bellido-Zapata A, Ruiz-Muggi JE, Neira-Sánchez ER, Málaga G. Implementación y aplicación de la “Guía de práctica clínica para el diagnóstico, tratamiento y control de la diabetes mellitus tipo 2 en el primer nivel de atención” en una red de establecimientos de salud públicos de Lima. Acta méd peru. 2018;14-9. Available from: http://www.scielo.org.pe/pdf/amp/v35n1/a03v35n1.pdf Accessed in 2021 (Dec 13).
Hadjadj S, Cariou B, Fumeron F, et al. Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes. Diabetologia. 2016;59(1):208-16. PMID: 26486355; https://doi.org/10.1007/s00125-015-3785-3.
Ahmad T, Ulhaq I, Mawani M, Islam N. Microalbuminuria in Type-2 Diabetes Mellitus; the tip of iceberg of diabetic complications. Pakistan J Med Sci. 2017;33(3):519-23. PMID: 28811763; https://doi.org/10.12669/pjms.333.12537.
Fu H, Liu S, Bastacky SI, et al. Diabetic kidney diseases revisited: A new perspective for a new era. Mol Metab. 2019;30:250-63. PMID: 31767176; https://doi.org/10.1016/j.molmet.2019.10.005.
Ansar MM, Shahrokhirad R, Lebady MK. Risk factors of microalbuminuria and macroalbuminuria in type 2 diabetic patients in north of Iran - Rasht. Nephrourol Mon. 2017;9(1):e40031. https://doi.org/10.5812/numonthly.40031.
Kundu D, Roy A, Mandal T, et al. Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes. Niger J Clin Pract. 2013;16(2):216-20. PMID: 23563465; https://doi.org/10.4103/1119-3077.110159.
National Campaign of World Kidney Day 2010; Peruvian Society of Nephrology. Microalbuminuria in adult outpatients not receiving nephrological care and with risk factors for chronic kidney disease in Peruvian nephrology departments. Nefrologia. 2012;32(2):180-6. PMID: 22425793; https://doi.org/10.3265/Nefrologia.pre2011.Nov.10865.
Herrera-Añazco P, Taype-Rondan A, Lazo-Porras M, et al. Prevalence of chronic kidney disease in Peruvian primary care setting. BMC Nephrol. 2017;18(1). PMID: 28724362; https://doi.org/10.1186/s12882-017-0655-x.
Naveen P, Venkatesan R, Ashwath Kumar R, Venkidusamy S. Effect of glycemic control on the incidence of microalbuminuria in type II diabetes mellitus individuals. Natl J Physiol Pharm Pharmacol. 2014;4(2):132-4. https://doi.org/10.5455/njppp.2014.4.211020131.
Muhammad R, Afridi MAR, Ali Z, Rahman SKU, Alam I. Microalbuminuria and its correlation with glycemic control in type 2 diabetic patients. J Postgrad Med Inst. 2018;32(3):301-6. Available from: https://jpmi.org.pk/index.php/jpmi/article/view/2411 Accessed in 2021 (Dec 13).
Hasan MJ, Muqueet A, Sharmeen A, Hoque MR. Prevalence of microalbuminuria in relation to glycemic control in type-2 diabetic patients in Mymensingh. Mymensingh Med J. 2015;24(1):18-4. PMID: 25725663.
Muraliswaran P, Aparna G, Kanagavalli P, Srikanth S. Association between Microalbuminuria and HbA 1 C among known Type 2 Diabetic patients in Puducherry population - A comparative study. IOSR J Biotechnol Biochem. 2016;2(6):15-7. Available from: https://www.iosrjournals.org/iosr-jbb/papers/Vol2-issue6/Version-1/D02061517.pdf
Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: Systematic review and meta-analysis. Arch Intern Med. 2012;172(10):761-9. PMID: 22636820; https://doi.org/10.1001/archinternmed.2011.2230.
Choi AI, Karter AJ, Liu JY, et al. Ethnic differences in the development of albuminuria: The DISTANCE study. Am J Manag Care. 2011;17(11):737-45. PMID: 22084893.
Jolly SE, Burrows NR, Chen SC, et al. Racial and Ethnic Differences in Albuminuria in Individuals With Estimated GFR Greater Than 60 mL/min/1.73 m2: Results From the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010;55(3 SUPPL. 2):S15-22. PMID: 20172444.
Sinha SK, Shaheen M, Rajavashisth TB, et al. Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney disease. Diabetes Care. 2014;37(4):1060-8. PMID: 24550221; https://doi.org/10.2337/dc13-0013.
Bryson CL, Ross HJ, Boyko EJ, Young BA. Racial and Ethnic Variations in Albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) Population: Associations With Diabetes and Level of CKD. Am J Kidney Dis. 2006;48(5):720-6. PMID: 17059991; https://doi.org/10.1053/j.ajkd.2006.07.023.
Ong SE, Kai Koh JJ, Toh SAES, et al. Assessing the influence of health systems on type 2 diabetes mellitus awareness, treatment, adherence, and control: A systematic review. PLoS ONE. 2018;13(3):e0195086. PMID: 29596495; https://doi.org/10.1371/journal.pone.0195086.
Thomas B. The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps. Curr Diab Rep. 2019;19(4):18. PMID: 30826889; https://doi.org/10.1007/s11892-019-1133-6.
Stevens PE, Levin A. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825-30. PMID: 23732715; https://doi.org/10.7326/0003-4819-158-11-201306040-00007.
Mongkolsomlit S, Patumanond J, Tawichasri C, Komoltri C, Rawdaree P. Meta-regression of risk factors for microalbuminuria in type 2 diabetes. Southeast Asian J Trop Med Public Health. 2012;43(2):455-66. PMID: 23082596.
Nuñez-Moscoso LE. Prevalencia de la microalbuminuria en pacientes con diabetes mellitus tipo 2 en un hospital de nivel 1 de Arequipa. Rev Soc Peru Med Interna. 2010;23(4):140-4. https://doi.org/10.36393/spmi.v23i4.384.
Herrera-Añazco P, Bonilla-Vargas L, Palacios-Guillén M, et al. Factors associated albuminuria in diabetic patients in her first nephrology consultation. Rev Nefrol Diálisis y Traspl. 2013;33(2):85-91. Available from: https://www.revistarenal.org.ar/index.php/rndt/article/view/165/157 Accessed in 2021 (Dec 13).
Esterson YB, Carey M, Piette JD, Thomas N, Hawkins M. A systematic review of innovative diabetes care models in low- and middle-income countries (LMICs). J Health Care Poor Underserved. 2014;25(1):72-93. PMID: 24509014; https://doi.org/10.1353/hpu.2014.0037.
Manne-Goehler J, Geldsetzer P, Agoudavi K, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med. 2019;16(3). PMID: 30822339; https://doi.org/10.1371/journal.pmed.1002751.
John L Kanagasabapathy AS. RPS. Prevalence of diabetic nephropathy in non-insulin dependent diabetics. Indian J Med Res. 1991;(94):24-9. PMID: 2071180.
Vijay V, Snehalatha C, Ramachandran A, Viswanathan M. Prevalence of proteinuria in non-insulin dependent diabetes. J Assoc Physicians India. 1994;42(10):792-4. PMID: 7876049.
Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgr Med J. 2001;77(908):399-402. PMID: 11375456; https://doi.org/10.1136/pmj.77.908.399.
Tam TK, Cheng LP, Lau DM, et al. The prevalence of microalbuminuria among patients with type II diabetes mellitus in a primary care setting: Cross-sectional study. Hong Kong Med J. 2004;10(5):307-11. PMID: 15479958.
Huraib S, Abu-Aisha H, Sulimani RA, et al. The pattern of diabetic nephropathy among Saudi patients with noninsulin-dependent diabetes mellitus. Ann Saudi Med. 1995;15(2):120-4. PMID: 17587920; https://doi.org/10.5144/0256-4947.1995.120.
Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225-32. PMID: 12472787; https://doi.org/10.1046/j.1523-1755.2003.00712.x.
Goyal B, Goyal J, Sinha M, Fiza B. Association of glycosylated hemoglobin with microalbuminuria in patients with type 2 diabetes mellitus. Int J Biotechnol Biochem. 2017;13(4):311-23. Available from: http://www.ripublication.com/ijbb17/ijbbv13n4_03.pdf Accessed in 2021 (Dec 13).
Acharya K, Regmi S, Sapkota AS, Raut M, Jha B. Microalbumin Status in Relation to Glycated Haemoglobin and Duration of Type 2 Diabetes Mellitus. Ann Clin Chem Lab Med. 2015;1(1):21-4. https://doi.org/10.3126/acclm.v1i1.12310.
Haffner SM, D’Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45(6):742-8. https://doi.org/10.2337/diab.45.6.742.
Ferrannini E, Gastaldelli A, Matsuda M, et al. Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: A physiological analysis. J Clin Endocrinol Metab. 2003;88(7):3251-7. PMID: 12843172; https://doi.org/10.1210/jc.2002-021864.
Ford ES, Maynard LM, Li C. Trends in mean waist circumference and abdominal obesity among US adults, 1999-2012. JAMA. 2014;312(11):1151-3. PMID: 25226482; https://doi.org/10.1001/jama.2014.8362.
Caballero AE. Understanding the Hispanic/Latino patient. Am J Med. 2011;124(10 Suppl):S10-5. PMID: 21939793; https://doi.org/10.1016/j.amjmed.2011.07.018.
Gil CL, Hooker E, Larrivée B. Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk. Kidney Med. 2021;3(1):105-115. PMID: 33604542; https://doi.org/10.1016/j.xkme.2020.10.005.
Sugahara M, Pak WLW, Tanaka T, Tang SCW, Nangaku M. Update on diagnosis, pathophysiology, and management of diabetic kidney disease. Nephrology. 2021;26(6):491-500. PMID: 33550672; https://doi.org/10.1111/nep.13860.
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4):S1-115. PMID: 32998798; https://doi.org/10.1016/j.kint.2020.06.019.
Bikbov MM, Fayzrakhmanov RR, Kazakbaeva GM, et al. Prevalence, awareness and control of diabetes in Russia: The Ural Eye and Medical Study on adults aged 40+ years. PLoS One. 2019;14(4):e0215636. PMID: 31009496; https://doi.org/10.1371/journal.pone.0215636.
Wang Q, Zhang X, Fang L, et al. Prevalence, awareness, treatment and control of diabetes mellitus among middle-aged and elderly people in a rural Chinese population: A cross-sectional study. PLoS One. 2018;13(6):e0198343. PMID: 29856828; https://doi.org/10.1371/journal.pone.0198343.
Aung WP, Bjertness E, Htet AS, Stigum H, Kjøllesdal MKR. Trends in diabetes prevalence, awareness, treatment and control in Yangon region, Myanmar, between 2004 and 2014, two cross-sectional studies. Int J Environ Res Public Health. 2019;16(18):3461. PMID: 31540348; https://doi.org/%2010.3390/ijerph16183461.
Pedro JM, Brito M, Barros H. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia among adults in Dande municipality, Angola. Cardiovasc J Afr. 2018;29(2):73-81. PMID: 29293258; https://doi.org/10.5830/CVJA-2017-047.
Sampaio E, Delfino VDA. Assessing albuminuria in spot morning samples from diabetic patients. Arq Bras Endocrinol Metabol. 2008;52(9):1482-8. PMID: 19197457; https://doi.org/10.1590/s0004-27302008000900012.
Witte EC, Heerspink HJL, De Zeeuw D, et al. First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol. 2009;20(2):436-43. PMID: 19092125; https://doi.org/10.1681/ASN.2008030292.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
